Journal article 675 views
Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients
Paul M Ridker,
James Revkin,
Pierre Amarenco,
Robert Brunell,
Madelyn Curto,
Fernando Civeira,
Marcus Flather,
Robert J. Glynn,
Jean Gregoire,
J. Wouter Jukema,
Yuri Karpov,
John J.P. Kastelein,
Wolfgang Koenig,
Alberto Lorenzatti,
Pravin Manga,
Urszula Masiukiewicz,
Michael Miller,
Arend Mosterd,
Jan Murin,
Jose C. Nicolau,
Steven Nissen,
Piotr Ponikowski,
Raul D. Santos,
Pamela F. Schwartz,
Handrean Soran,
Harvey White,
R. Scott Wright,
Michal Vrablik,
Carla Yunis,
Charles L. Shear,
Jean-Claude Tardif,
Julian Halcox
New England Journal of Medicine, Volume: 376, Issue: 16, Pages: 1527 - 1539
Swansea University Author:
Julian Halcox
Full text not available from this repository: check for access using links below.
DOI (Published version): 10.1056/NEJMoa1701488
Abstract
Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients
Published in: | New England Journal of Medicine |
---|---|
ISSN: | 0028-4793 1533-4406 |
Published: |
2017
|
Online Access: |
Check full text
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa34614 |
Item Description: |
SPIRE Cardiovascular Outcome Investigator |
---|---|
College: |
Faculty of Medicine, Health and Life Sciences |
Issue: |
16 |
Start Page: |
1527 |
End Page: |
1539 |